Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Navidea reports further phase IIb data on Tc99m tilmanocept imaging for rheumatoid arthritis

Nov. 13, 2020

New immune checkpoint antibody AbGn-168H displays promising efficacy and is well tolerated

Nov. 12, 2020

Corbus reports post-hoc analyses of RESOLVE-1 study of lenabasum for systemic sclerosis

Nov. 11, 2020

Promising phase II data for deucravacitinib in active psoriatic arthritis

Nov. 11, 2020

First-in-human data for LNA-043 as treatment of knee osteoarthritis

Nov. 11, 2020

SHR-0302 displays dose-dependent effects in rheumatoid arthritis

Nov. 11, 2020

Active pipeline of potential new lupus therapies unfolding as ACR begins

Nov. 6, 2020

Macrophages metabolically support muscle

Nov. 5, 2020

Discovery of novel highly potent ghrelin receptor full agonists

Oct. 20, 2020

Phase II trial of GLPG-1972 in osteoarthritis does not meet primary objective

Oct. 16, 2020

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...